Trials / Terminated
TerminatedNCT04717024
The Nanowear Wearable Covid-19 Observational and Analysis Trend
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Nanowear Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The NanoCOAT study is a multi-center, prospective, non-randomized, feasibility, observational, non-significant risk study. The NanoCOAT study will enroll a minimum of 10 and a maximum of 100 subjects in a potential for a multi-site in order to collect data and analyze physiological and biometric trends due to Covid-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Observational Study - no intervention | Observational Study - no intervention |
Timeline
- Start date
- 2020-09-15
- Primary completion
- 2021-04-15
- Completion
- 2021-04-30
- First posted
- 2021-01-20
- Last updated
- 2026-04-09
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04717024. Inclusion in this directory is not an endorsement.